Medical Weight Loss
Clinician-supervised evaluation for a compounded tirzepatide injection, a GIP/GLP-1 receptor agonist.
$249 /month
Start your visit →Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Several FDA-approved branded tirzepatide products exist; no branded tirzepatide product is sold through the TelePep store. Where clinically appropriate after individualized medical evaluation, an independent licensed clinician with Lone Star Virtual Health PLLC may prescribe a compounded tirzepatide injection tailored to the specific patient. The compounded preparation is dispensed by a licensed US compounding pharmacy. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of any branded product, and are not represented as therapeutically equivalent.
Administration
If prescribed, a subcutaneous injection you give yourself, usually once a week, per the clinician's instructions.
Frequency
As directed by the prescribing clinician.
Program Track
Medical Weight Loss
Pricing
$249 /month
Plans: $249/month, $711 for 3 months, $1,344 for 6 months, or $2,568 for a year (about $214/month, billed annually).
Your payment method is authorized for the plan price at checkout. You are charged only after a licensed clinician prescribes and your order is sent to the pharmacy. If no prescription is issued, the hold is released and you are not charged.
How It Works
Tirzepatide is a synthetic peptide that acts at the GIP and GLP-1 receptors. Mechanism information is provided for general education. Whether tirzepatide is clinically appropriate for an individual patient is a determination made by the prescribing clinician based on full medical history and evaluation.
Key points
Eligibility
Adults seeking clinician-supervised medical weight-management evaluation. Eligibility and dose are determined individually by your prescribing clinician based on full medical history. Not appropriate for patients with certain contraindications including a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or known hypersensitivity.
Clinical supervision required. Eligibility for this program is determined by your prescribing clinician based on individual medical history. Not all patients will qualify.
FAQ
No. Compounded preparations are not FDA-approved drugs, are not generic versions of branded medications, and are not represented as therapeutically equivalent. Whether a compounded preparation is appropriate for a given patient is an individualized clinical decision.
GLP-1 receptor agonists may cause nausea, vomiting, diarrhea, constipation, decreased appetite, and other effects, particularly during dose escalation. Rare but serious risks (including pancreatitis and thyroid-related concerns) are reviewed against your history by the prescribing clinician before any prescription is issued.
Tirzepatide: $249/month, $711 for 3 months, $1,344 for 6 months, or $2,568 for a year (about $214/month, billed annually). Your payment method is authorized for the plan price at checkout. You are charged only after a licensed clinician prescribes and your order is sent to the pharmacy. If no prescription is issued, the hold is released and you are not charged.
Independent licensed clinicians with Lone Star Virtual Health PLLC review every intake through the Bask Health platform and decide whether a prescription is appropriate.
Compounded tirzepatide is available in 48 US states plus the District of Columbia and Puerto Rico (not Arkansas or Hawaii). NAD+ injection and sermorelin troche are also available in Arkansas and Hawaii.
Ships from a licensed US compounding pharmacy, typically 2–10 days after your prescription is issued; some orders take longer.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Individual results vary; no outcome is guaranteed.
Complete the online intake on the TelePep store. A licensed clinician reviews it and decides whether a prescription is appropriate.